Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × bicalutamide × Clear all

Phase

Status

Completed 2 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 9 Breast Neoplasms 2 Polycystic Ovary Syndrome 1 Neoplasm Metastasis 1 Metabolic Diseases 1 Hyperandrogenism 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Fluorouracil 18 Oxaliplatin 15 Capecitabine 15 Leucovorin 13 Irinotecan 11 Gemcitabine 10 Drug Therapy 10 Radiosurgery 9 Cisplatin 9 Cetuximab 9 Bevacizumab 9 Docetaxel 8 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 spartalizumab 5 pembrolizumab 5 Sunitinib 5 S 1 (combination) 5 Cyclophosphamide 5 Chemotherapy, Adjuvant 5 Carboplatin 5 manganese chloride 4 Trastuzumab 4 Surgical Procedures, Operative 4 Sorafenib 4 Nivolumab 4 Immunotherapy 4 Fulvestrant 4 Everolimus 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02353988 2015-02-03

Arbre

Jinling Hospital, China

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡